First trimester serum PAPP-A is associated with placenta accreta: a retrospective study
- PMID: 33515274
- DOI: 10.1007/s00404-020-05960-1
First trimester serum PAPP-A is associated with placenta accreta: a retrospective study
Abstract
Purpose: Our objective of this study was to investigate whether first trimester serum pregnancy-associated plasma protein-A (PAPP-A) differed amongst pregnancies with placenta previa-accreta and non-adherent placenta previa and healthy pregnancies by a retrospective cohort analysis.
Methods: A total of 177 pregnant females were included in the study, as follows: 35 cases of placenta previa-accreta, 30 cases of non-adherent placenta previa, and 112 cases of BMI and age matched, healthy pregnant controls. PAPP-A multiples of the median (MoM) were acquired from laboratory data files in 1 January 2017-30 September 2019. The probable maternal serum biochemical predictor of placenta accreta was analyzed by using multiple logistic regression analysis.
Results: PAPP-A MoM of placenta previa-accreta group was significantly higher than those of the non-adherent placenta previa group and control group (p = 0.009 < 0.05, p < 0.001). Serum PAPP-A was found to be significantly positively associated with placenta accreta after adjusted gestational week at time of blood sampling, BMI, age, smoking, and previous cesarean section history (OR: 3.51; 95% CI: 1.77-6.94; p = 0.0003 < 0.05). In addition, smoking (OR: 9.17; 95% CI: 1.69-49.62; p = 0.010 < 0.05) and previous cesarean section history (OR: 2.75; 95% CI: 1.23-6.17; p = 0.014 < 0.05) were also significantly associated with placenta accreta.
Conclusion: Increased first trimester serum PAPP-A was significantly positively associated with placenta accreta, suggesting that the potential role of PAPP-A in identifying pregnancies at high risk for placenta accreta. Smoking and previous cesarean section history may be the risk factors for accreta in placenta previa patients.
Keywords: Association; First trimester serum; PAPP-A; Placenta accreta.
References
-
- Su HW, Yi YC, Tseng JJ, Chen WC, Chen YF, Kung HF, Chou MM (2017) Maternal outcome after conservative management of abnormally invasive placenta. Taiwan J Obstetr Gynecol 56(3):353–357. https://doi.org/10.1016/j.tjog.2017.04.016 - DOI
-
- Higgins MF, Monteith C, Foley M, O’Herlihy C (2013) Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section. Eur J Obstet Gynecol Reprod Biol 171(1):54–56. https://doi.org/10.1016/j.ejogrb.2013.08.030 - DOI - PubMed
-
- Silver RM (2015) Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol 126(3):654–668. https://doi.org/10.1097/AOG.0000000000001005 - DOI - PubMed
-
- Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V (2011) Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand 90(10):1140–1146. https://doi.org/10.1111/j.1600-0412.2011.01147.x - DOI - PubMed
-
- Comstock CH, Love JJ Jr, Bronsteen RA, Lee W, Vettraino IM, Huang RR, Lorenz RP (2004) Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol 190(4):1135–1140. https://doi.org/10.1016/j.ajog.2003.11.024 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
